EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC-ND 4.0

Toward a serum biomarker of disease activity in Susac syndrome

Todd A Hardy iD

European Journal of Neurology · 2023

DOI: 10.1111/ene.15984 ↗

Kurz gefasst

Kommentar in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Todd A Hardy. Beteiligte Einrichtung: Multiple Sclerosis and Neuroimmunology Clinic, Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Susac Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Susac SyndromeHumansMagnetic Resonance ImagingBiomarkersGlial Fibrillary Acidic Protein

Stichwörter der Autor:innen

BEE syndromeGFAPRED-MSICRETbrain-eye-earendotheliopathyglial fibrillary acidic proteinretinocochleocerebral vasculopathysNfLserum neurofilament lightvasculitis

Substanzen

BiomarkersGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Multiple Sclerosis and Neuroimmunology Clinic, Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Todd A Hardy

Zitieren

APA

Hardy, T. A. (2023). Toward a serum biomarker of disease activity in Susac syndrome. European Journal of Neurology. https://doi.org/10.1111/ene.15984

Vancouver

Hardy TA. Toward a serum biomarker of disease activity in Susac syndrome. European Journal of Neurology. 2023. doi:10.1111/ene.15984

BibTeX
@article{Hardy2023,
  author = {Hardy, Todd A},
  title = {Toward a serum biomarker of disease activity in Susac syndrome},
  journal = {European Journal of Neurology},
  year = {2023},
  doi = {10.1111/ene.15984}
}
Kostenlos starten →